tm
Seeing Is Believing
tm
Seeing Is Believing
CRXT is currently covered by 3 analysts with an average price target of $7.53. This is a potential upside of $7.53 (0%) from yesterday's end of day stock price of $0.
Clarus Therapeutics Holdings's activity chart (see below) currently has 3 price targets and 8 ratings on display. The stock rating distribution of CRXT is 50% BUY and 50% HOLD.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 23-Aug-2022. First documented stock forecast 21-Sep-2021.
Currently out of the existing stock ratings of CRXT, 2 are a BUY (50%), 2 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 8 months 2 days ago
0/1 (0%)
$8.35 (228.77%)
Hold
13
1 years 8 months 3 days ago
0/1 (0%)
$8.7 (202.33%)
Buy
10
1 years 11 months 8 days ago
0/1 (0%)
$4.78 (91.57%)
Buy
12
2 years 14 days ago
0/1 (0%)
$3.91 (48.33%)
Buy
20
2 years 14 days ago
0/1 (0%)
$11.91 (147.22%)
What is CRXT (Clarus Therapeutics Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on CRXT (Clarus Therapeutics Holdings) with a proven track record?
Which analyst has the current lower performing score on CRXT (Clarus Therapeutics Holdings) with a proven track record?
Which analyst has the most public recommendations on CRXT (Clarus Therapeutics Holdings)?
Which analyst is the currently most bullish on CRXT (Clarus Therapeutics Holdings)?
Which analyst is the currently most reserved on CRXT (Clarus Therapeutics Holdings)?
